Danaher Corporation
American conglomerate
Follow Danaher Corporation on Notably News to receive short updates to your email — rarely!
June 2024 | The US Food and Drug Administration (FDA) granted marketing approval to Danaher's Cepheid unit for a rapid hepatitis C test that can detect virus RNA from a fingertip blood sample in less than an hour. |
April 2024 | Precision Nanosystems was merged into Cytiva. |
September 30 2023 | Danaher completed the separation of Veralto, which began trading on the New York Stock Exchange on October 2 under the symbol 'VLTO'. |
September 19 2023 | Cepheid and Danaher announce a 20% price reduction for their Xpert MTB/RIF TB test cartridge, lowering the price from $9.98 to $7.97 in high TB-burden countries, following public pressure. |
September 12 2023 | Author and vlogger John Green releases a video raising ethical concerns about the pricing of Cepheid's test cartridges and mobilizes his community to take action against Danaher. |
August 28 2023 | Danaher entered into a definitive agreement to acquire Abcam for approximately $5.7 billion at $24 per share in cash. |
February 8 2023 | Danaher announced the new spun-off company would be named Veralto Corporation, to be led by Jennifer Honeycutt as President and CEO. |
September 2022 | Danaher announced its intention to spin off the Environmental & Applied Solutions segment in Q4 2023. |
September 2022 | Danaher announced the merger of Pall Life Sciences with Cytiva to create a new Biotechnology Group, which was completed in May 2023. |
September 1 2020 | Rainer Blair replaced Tom Joyce as CEO of Danaher Corporation. |
May 2020 | Announcement made that Tom Joyce would retire as CEO of the company. |
March 2020 | Danaher acquired the biopharma business of General Electric Life Sciences division for $21.4 billion, renamed Cytiva. |
March 2 2020 | FDA Commissioner Dr. Stephen Hahn referenced Integrated DNA Technologies (a Danaher division) in discussing expanded coronavirus testing capacity. |
2019 | Treatment Action Group and Doctors Without Borders begin advocating for Cepheid to lower the prices of disease test cartridges for COVID-19, HIV, and tuberculosis. |
October 2019 | Danaher announced it would sell its biomolecular characterization, chromatography hardware and resins, microcarriers and particle validation standards businesses to Sartorius AG for approximately $750 million. |
July 2018 | Danaher announced its intention to spin off its $2.8 billion Dental segment into an independent publicly traded company, with Amir Aghdaei to be President and CEO of the new company. |
March 2018 | Danaher announced it would acquire Integrated DNA Technologies for an undisclosed price. |
October 2017 | Danaher announced the acquisition of scientific informatics company ID Business Solutions Ltd. (IDBS), which would become part of Danaher's Life Sciences platform. |
October 2016 | Danaher Corporation acquired Phenomenex for $700 million to expand its life sciences space. |
September 2016 | Danaher announced it would acquire Cepheid for $4 billion (including debt). |
June 2016 | Danaher spun off several subsidiaries, including Matco and AMMCO-COATS, to create Fortive. |
May 2015 | Danaher announced the acquisition of Pall Corporation for $13.8 billion, completed in August 2015. |
October 2014 | Danaher Corp announced it would be combining its communications unit with NetScout Systems, which was completed in July 2015. |
September 2014 | Danaher announced its intention to buy Nobel Biocare for $2.2 billion. |
December 2012 | Danaher Corporation acquired Navman Wireless, a provider of on-demand fleet and asset management technology. |
October 2012 | Danaher and Cooper Industries agreed to sell their joint venture, Apex Tool Group, to Bain Capital for approximately $1.6 billion. |
2011 | Danaher acquired Beckman Coulter and sold Accu-sort to Datalogic. |
This contents of the box above is based on material from the Wikipedia article Danaher Corporation, which is released under the Creative Commons Attribution-ShareAlike 4.0 International License.